What is the purpose of this joint research?

To establish objective indicators for assessing the health of cartilaginous fish such as whale sharks and to improve animal welfare and husbandry management.

What technology is used to evaluate health status?

We use the 'aiwell IPA' platform, an AI-based protein biomarker discovery platform developed by aiwell Inc., to analyze blood components.

Which companies and organizations are participating in the research?

The research is a joint effort involving the Okinawa Churaumi Foundation, aiwell Inc., and Sumitomo Corporation Hokkaido.

AI News NQ Analysis

[Okinawa Churashima Foundation] Initiates Joint Research with aiwell Inc. and Sumitomo Corporation Hokkaido to 'Visualize' the Health of Whale Sharks, Aiming to Visualize the Health Status of Cartilaginous Fish

NQ Score 80/100

N1 Content Completeness 9

AI Summary (NQ-processed)

Okinawa Churashima Foundation, aiwell, and Sumitomo Corporation Hokkaido have started a joint research project to establish objective health metrics for whale sharks and manta rays using AI-based protein biomarker analysis tech.

AI Analysis

Frequently Asked Questions

Q: What is the purpose of this joint research?: A: To establish objective indicators for assessing the health of cartilaginous fish such as whale sharks and to improve animal welfare and husbandry management.
Q: What technology is used to evaluate health status?: A: We use the 'aiwell IPA' platform, an AI-based protein biomarker discovery platform developed by aiwell Inc., to analyze blood components.
Q: Which companies and organizations are participating in the research?: A: The research is a joint effort involving the Okinawa Churaumi Foundation, aiwell Inc., and Sumitomo Corporation Hokkaido.